Home  /  Resource Library  /  Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult leukemia group

Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult leukemia group

Study investigated venetoclax combined with obinutuzumab for first line treatment of CLL.